Gilbert, AZNCT07037758Now EnrollingIRB Ready

Extensive Stage Small Cell Lung Cancer Clinical Trial in Gilbert, AZ

Access cutting-edge extensive stage small cell lung cancer treatment through this clinical trial at a research site in Gilbert. Study-provided care at no cost to qualified participants.

Sponsored by Amgen

Quick Self-Assessment

See if you qualify for this Gilbert location

Preparing your pre-screening questions…

Expert Care in Gilbert

Access extensive stage small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related extensive stage small cell lung cancer treatment provided free

Apply for This Gilbert Location

Check if you qualify for this extensive stage small cell lung cancer clinical trial in Gilbert, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gilbert

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gilbert site if eligible
  4. 4Begin participation

About This Extensive Stage Small Cell Lung Cancer Study in Gilbert

The primary objective for dose exploration and dose expansion is to evaluate the safety and tolerability of tarlatamab in combination with AB248. The primary objective for dose exploration only is to determine the recommended dose for expansion and/or maximum tolerated combination dose (MTCD) of AB248 in combination with tarlatamab.

Sponsor: Amgen

Who Can Participate

Inclusion Criteria

Participant has provided informed consent before initiation of any study-specific activities/procedures.
Participants ≥ 18 years (or ≥ legal age within the country if it is older than 18 years) at the time of signing the informed consent.
Participants with histologically or cytologically confirmed ES-SCLC that has progressed or recurred following at least 1 line of anti-cancer therapy for ES-SCLC.
Participants must have at least 1 measurable lesion as defined by RECIST 1.1 within 21-day screening period, not previously irradiated.
Participants must have adequate organ function (hematological, coagulation, cardiac, pulmonary, kidney, and liver).
Participants must submit a fresh tumor biopsy at screening unless a new biopsy cannot be performed safely or is infeasible. Participants who cannot provide fresh tissue may provide archival tissue that was collected after last anticancer therapy.

Exclusion Criteria

Symptomatic central nervous system (CNS) metastases.
Participants with brain metastases may be eligible if criteria defined in the protocol are met.
Prior therapy with any delta-like ligand 3 (DLL3)-directed therapy (including tarlatamab).
Prior interleukin (IL)-2, IL-7 or IL-15 targeted therapy.
Baseline (at rest) requirement of supplemental oxygen.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gilbert?

Yes, this clinical trial (NCT07037758) has an active research site in Gilbert, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Extensive Stage Small Cell Lung Cancer Treatment Options in Gilbert, AZ

If you're searching for extensive stage small cell lung cancer treatment options in Gilbert, AZ, this clinical trial (NCT07037758) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gilbert research site is actively enrolling participants for this clinical trial. You'll receive care from experienced extensive stage small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all extensive stage small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Gilbert, AZ

See all lung cancer clinical trials recruiting in Gilbert — not just this study.

Browse Lung Cancer Trials in Gilbert →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Gilbert?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gilbert, AZ